REPROS THERAPEUTICS INC - COM NEW (RPRX)

CUSIP: 76028H209

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Equity / COM NEW
Total 13F shares
2,221,916
Share change
+176,137
Total reported value
$59,547,000
Put/Call ratio
40%
Price per share
$26.80
Number of holders
6
Value change
+$4,720,443
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 76028H209?
CUSIP 76028H209 identifies RPRX - REPROS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REPROS THERAPEUTICS INC - COM NEW (RPRX) as of Q3 2013

As of 30 Sep 2013, REPROS THERAPEUTICS INC - COM NEW (RPRX) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,221,916 shares. The largest 6 holders included Citadel Advisors LLC, Partner Fund Management, L.P., PDT Partners, LLC, Partner Investment Management, L.P., BANK OF MONTREAL /CAN/, and WELLS FARGO & COMPANY/MN. This page lists 6 institutional shareholders reporting positions in this security for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.